A phase II, double-blind, randomised placebo-controlled trial of EpiCept NP-1 topical cream in patients with chemotherapy-induced peripheral neuropathy.
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2011
At a glance
- Drugs Amitriptyline/ketamine (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Immune Pharmaceuticals Inc
- 07 Feb 2011 Positive preliminary results reported in an EpiCept media release.
- 07 Feb 2011 Primary endpoint 'Pain-intensity' has been met, as reported in an EpiCept media release.
- 11 Nov 2010 New trial record